Previous studies have infused radiolabeled arachidonic acid (AA) into rat brains and followed AA esterification into phospholipids for up to 24 hours; however, the half-life of AA in rat brain phospholipids is unknown. Eighteen day old rats were fed either an n-3 PUFA adequate or of AA in rat brain phospholipids was 44 ± 4 days for the n-3 PUFA adequate group and 46 ± 4 days for the n-3 PUFA deprived group, which closely approximates the predicted half-life previously reported, based on the rate of entry from the plasma unesterified pool, suggesting the plasma unesterified pool is a major contributor to brain uptake of AA. Furthermore, unlike a previous report in which the half-life of brain phospholipid docosahexaenoic acid (DHA) was increased in n-3 PUFA deprived rats, n-3 PUFA deprivation did not significantly alter the AA half-life, suggesting different mechanisms exist to maintain brain concentrations of AA and DHA.
INTRODUCTION
The polyunsaturated fatty acids (PUFA) docosahexaenoic acid (DHA; 22:6n-3) and arachidonic acid (AA; 20:4n-6) have been increasingly recognized as biochemically potent compounds in the human diet playing an important role in the nervous system (1) (2) (3) . DHA and AA may be consumed directly through the diet or they may be synthesized de novo through hepatic desaturation and elongation of their precursors, alpha-linolenic acid (ALA; 18:3n-3) and linoleic acid (LA; 18:2n-6), respectively (4) (5) (6) (7) (8) . The rate of brain desaturation and elongation of plasma unesterified ALA and LA into DHA and AA, respectively, has been shown to be <1% of the brain rate of uptake of preformed DHA and AA from plasma in vivo (7, 9) . One area of interest in these PUFA is with regards to brain development and function, as the brain is highly enriched in both DHA and AA (10) . Currently, DHA is being investigated for its potential neuroprotective and anti-inflammatory properties (11) (12) (13) . Alternatively, understanding AAmediated signal-transduction and metabolism within the brain may provide insight into a variety of neurological and neurodegenerative disorders. Several studies have shown widely-used mood stabilizers target turnover and enzymatic pathways of AA (14, 15) . Other studies have implicated upregulated AA signalling cascades in Alzheimer's disease and vascular dementia (16) , Multiple Sclerosis (17) , and Parkinson's disease (18, 19) .
AA entry into the brain may originate from several sources, including the plasma unesterified pool, or via lipoproteins including high-density, low-density, and very low-density lipoproteins (HDL, LDL, and VLDL); lipoprotein receptors have been identified on the blood brain barrier (20) . Chen et al. examined the contribution of the LDL pathway of PUFA entry into the brain by comparing brain phospholipid PUFA levels in LDL-knockout and wild-type mice, and found no significant difference (21) . However, it is unknown whether other pathways of entry (HDL, VLDL, unesterified, lysophosphatidylcholine, etc.) compensated for the lack of influx from the LDL pool. Contreras et al. infused unesterified radiolabeled AA into the femoral vein of awake third-generation n-3 PUFA deprived rats and calculated the rate of unesterified AA entry into brain phospholipids J in,i(plasma unesterified AA) (22) . From this calculation, a mathematical model can be used to predict an AA half-life in rat brain phospholipids (equation 1: ln(2)*c brain,i(phospholipid AA) /J in,i(plasma unesterified AA) , where c brain,i(phospholipid AA) is the concentration of AA in brain phospholipid i, and J in,i(plasma unesterified AA) is the net rate of AA entry from the plasma unesterified pool into brain phospholipid i.), which was determined to be 42 days and 48 days for n-3 PUFA adequate and n-3 PUFA deprived animals, respectively. However, this rate of AA loss from brain phospholipids is predicted exclusively by the rate of entry of plasma unesterified AA into the brain. Similarly, Positron Emission Tomography (PET) studies in humans using unesterified [1- 11 C] AA have calculated a brain AA incorporation rate J in,i(plasma unesterified AA) of 17.8 mg/day (2, 23) . However, these studies did not take into account other potential sources of AA, including lipoprotein-transported AA or an as-yet-unidentified source.
Two distinct brain phospholipid PUFA half-lives have been described (24, 25) . In one method, upon infusion of a unesterified radiolabeled PUFA into the plasma, the net rate of entry from the plasma unesterified pool is used to calculate the half-life of replacement in brain phospholipids according to equation 1: ln(2)*c brain,i(phospholipid PUFA) /(J in,i(plasma unesterified PUFA) ) (see above). Because brain phospholipid concentrations are relatively stable over time (24) , if plasma unesterified PUFA are a major contributor to brain phospholipids then the J in,i(plasma unesterified PUFA)
should closely approximate the net rate of loss of PUFA from brain phospholipids J out,i(brain phospholipid PUFA) which can be measured directly by labelling brain phospholipids with a PUFA radiotracer and measuring the loss over time (4, 24) . Indeed, DHA's half-life from brain phospholipids (33 days) approximates the rate of replacement from the plasma unesterified DHA pool, suggesting that for DHA J in,i(plasma unesterified DHA) ≅ J out,i(brain phospholipid DHA) (4, 24) . By correcting for potential dilution from sources besides the plasma unesterified PUFA pool, Rapoport and colleagues have developed a method to calculate the net rate of PUFA uptake into brain phospholipids from the PUFA-CoA pool (J FAi,(brain phospholipid PUFA) ) (25) (26) (27) . This is accomplished by correcting J in,i(plasma unesterified PUFA) for the ratio of the specific activity of the AA is recognized as a significant component in neuronal cell membranes not only due to its effects on phospholipid membrane fluidity, but through its role in signal-transduction (2, 32) .
These signalling cascades may play a crucial role in the development and treatment of a variety of psychiatric and neurological disorders. Therefore, it is important to understand how AA enters the brain from the plasma, the dynamics of AA turnover, and kinetic control once in the brain. In the current study we measured the rate of AA loss from rat brain phospholipids directly, by injecting radiolabeled AA into the brains of rats consuming either an n-3 PUFA adequate or deprived diet (24, 33, 34) . Brain phospholipid radiolabeled AA levels were measured over multiple time points to determine the rate of loss and compared to previously predicted half-lives based on the rate of entry from the plasma unesterified pool (22) in an attempt to determine if the unesterified AA pool is a significant contributor to brain phospholipid AA. Brain phospholipid AA half-lives calculated in this study closely match the predicted half-lives from the unesterified fatty acid pool.
MATERIALS AND METHODS

Animals
The protocol was approved by the Department of Comparative Medicine at the University of Toronto. Eighteen-day old male Long Evans pups and their dams were purchased from Charles River Laboratories (Saint -Constant, Quebec). The pups were allowed to nurse for 3 days.
When they reached 21 days of age, they were removed from the dams and fed either an n-3
PUFA adequate or n-3 PUFA deprived diet, as described below. The pups were maintained on their assigned diet for the duration of the study. The rats were housed at 22 o C under a 12 h light/dark cycle with ad libitum access to food and water. (22, 24, 35, 36) . Dietary fat came from adding select amounts of hydrogenated coconut, safflower or flaxseed oils. Hydrogenated coconut (6% and 6.6% by weight, n-3 PUFA adequate and deprived, respectively) and safflower oil (3.2% and 3.4% by weight, n-3 PUFA adequate and deprived, respectively) were added to both diets as a base.
Flaxseed oil (0.8% by weight) was added to the n-3 PUFA adequate diet to provide ALA at approximately 3.3% of total fatty acids. The n-3 PUFA deprived chow was very low in ALA (0.15% of total fatty acids). Lauric (12:0), myristic (14:0), palmitic (16:0) and stearic (18:0) saturated fatty acids comprised approximately 39, 14, 9, and 7% of the total fatty acids for the n-3 PUFA adequate chow, respectively. The n-3 PUFA deprived chow had a similar saturated fatty acid profile, but contained a higher percentage of lauric acid (42%), compared to the n-3
PUFA adequate diet, to compensate for the lack of n-3 fatty acids. Both diets contained safflower oil to provide LA as approximately 21% of total fatty acids. All 20+ carbon chain fatty acids amounted to less than 0.05% of total fatty acids in both diets. LA and ALA were set at 6%
and 1% of total caloric intake (3935 kcal/kg), giving a ratio of ~6:1 in the n-3 PUFA adequate diet. Dietary fatty acid composition was confirmed by GC analysis (see below). for 5 minutes following the end of the injection, after which it was removed at a rate of 1 mm/min, and the hole sealed with cranioplastic cement. The wound was closed with selfdissolving sutures and swabbed with iodine. For pain control, 1% sensocaine solution was injected under the scalp and a subcutaneous injection of 1 mL 0.9% saline was given to prevent dehydration. Animals were placed in a recovery cage with a heat-lamp and then returned to their respective n-3 PUFA adequate or deficient diets, where they remained until the end of the study. 
Collection of brains
Quantitation of phospholipid radioactivity and fatty acid concentrations
Brain phospholipid bands were scraped from TLC plates into scintillation vials with 5 ml of scintillation cocktail (ASC; GE Healthcare Bio-sciences Corp., Piscataway, NJ) and counted using a Packard TRI-CARB2900TR liquid scintillation counter (GMI, Ramsey, MN) with a detector efficiency of 47.7%. Radioactivities (dpm) were adjusted for counting efficiency and converted to curies (Ci). To determine fatty acid concentrations in each phospholipid, TLC scrapes were methylated using 14% boron trifluoride-methanol at 100˚C for 1 hour. Prior to methylation, di-17:0 phosphatidylcholine was added as an internal standard to brain phospholipids. Fatty acid methyl esters (FAMEs) from total brain phospholipids, phospholipid fractions, and rodent chow were analyzed using a Varian-430 gas chromatograph (Varian, Lake 
Confirmation of Radiotracer Identity
Radiotracer 
RESULTS
Bodyweights
Rat bodyweights (735 ± 57, 716 ± 69 g, n-3 PUFA adequate and deprived groups, respectively) did not differ statistically (p=0.2) after 15 weeks of n-3 PUFA adequate or deprived diet.
Tracer identification and Brain Phospholipid PUFA Concentrations
Brain samples (Day 4 and 120 time point, post-surgery, n-3 PUFA adequate and deprived diet)
were analyzed by HPLC to confirm successful infusion of the perfusate into the brain; 20:4n-6 eluded at 33.5 min, and total phospholipid radioactivity was > 94 % AA. Trace amounts of radioactivity (< 6 %) were eluted at 45 min. Because this peak was also found in the perfusate, it is not possible to associate this to brain metabolism. We also analysed the 20:4n-6 fraction obtained from the HPLC by GC/FID and did not detect any other PUFA in this fraction. Table 1 shows the values for esterified fatty acids in brain phospholipid classes, from n-3 PUFA adequate and deprived rats, measured after 15 weeks of feeding. DHA concentrations in total brain phospholipids were 27% lower in the n-3 PUFA deprived group, compared to the n-3 PUFA adequate group. DHA was also lower in phospholipid fractions of the n-3 PUFA deprived rats (ChoGpl-29%, EtnGpl-24%, PtdIns-50%, PtdSer-31%), compared to the n-3 PUFA adequate group (p<0.05). The n-6 PUFA docosapentaenoic acid (DPA; 22:5n-6) was significantly elevated in the n-3 PUFA deprived group compared to the n-3 PUFA adequate group across all phospholipid classes (p<0.001). AA was significantly higher in total brain phospholipids and ethanolamine glycerophospholipids from the n-3 PUFA deprived group compared to the n-3
PUFA adequate group, whereas myristic acid (14:0) was significantly higher in PtdSer in the n-3
PUFA deprived group (p<0.05). See Table 1 for other fatty acids.
Brain Phospholipid AA Half-lives
Total brain phospholipid and phospholipid fraction radioactivity was plotted over time (days) following surgery ( Figure 1 ). Slopes for all phospholipid classes among both dietary groups were significantly different from zero (p<0.0001). Linear regression analysis of slopes showed no statistical difference between n-3 PUFA adequate and deprived groups across all phospholipid classes (p>0.05). Half-lives are shown in Table 2 , ranging from 26 to 51 days for the n-3 PUFA adequate group, and from 28 to 57 days for the n-3 PUFA deprived group. No significant differences were found for the half-lives between the groups (p>0.05). Within the dietary groups, the half-lives of AA in both EtnGpl and PtdSer were significantly longer than the half- (Table 2) .
DISCUSSION
Dietary deprivation of n-3 PUFA in rats has previously been shown to result in a 27-37% decrease in brain phospholipid DHA following 15 weeks of feeding, compared to the n-3 PUFA adequate diet (24, 33, 34) ; we observed a significant total brain phospholipid DHA decrease of 27% in our n-3 PUFA deprived group compared to the n-3 PUFA adequate group (from 9.9 to 7.3 µmol/ g brain). Furthermore, after 15 weeks, total phospholipid AA was significantly increased in the n-3 PUFA deprived group; this effect has been previously reported (47, 48 ) and brain PUFA concentrations appear to be stable upon 15 weeks of adequate or deprived feeding (24) .
We also observed a 2000% increase in total phospholipid n-6 DPA in the n-3 PUFA deprived group compared to the n-3 PUFA adequate group (from 0.2 to 4 µmol/ g brain), which is consistent with observations from other studies (22, 24, 33) . Because the brain appears limited in its ability to desaturate/elongate 18:2n-6 (7), it is possible that 22:5n-6 was formed in the liver and transported to the brain. Past studies have examined brain AA metabolism for ≤ 24 hours following i.c.v. injection in the lateral ventricle (37, 49) , giving us the opportunity to measure brain phospholipid AA loss over a greater time period (4-120 days). We calculated the half-life of AA in rat brain total phospholipids to be 44 ± 4 and 46 ± 4 days, for the n-3 PUFA adequate and deprived groups, respectively; these half-lives represent the rate of AA metabolic consumption, and not the more rapid kinetic rate of recycling into the phospholipid membrane.
The half-lives for phospholipid fractions ranged from 26 (PtdIns) to 51 (PtdSer) days in the n-3 PUFA adequate group, and 28 (ChoGpl, PtdIns) to 57 (PtdSer) days in the n-3 PUFA deprived group; however, the differences were not significant between the dietary groups. This finding is consistent with slower rates of brain AA incorporation into EtnGpl and PtdSer, compared to
ChoGpl and PtdIns, observed in other studies (50, 51) . It should be noted, that i.c.v. infusion can induce inflammation and damage to the BBB (52). To minimize this we used a 33 gauge needle and allowed the animal to recover for 4-120 days prior to measuring brain phospholipid radioactivity. This procedure has been widely used to deliver compounds including fatty acids to the brain (24, 37, 49, (53) (54) (55) .
With growing evidence implicating brain AA signalling in neurological and psychiatric disorders (2, (16) (17) (18) , manipulation of brain phospholipid AA concentration appears to be a likely direction for future research (2, 56), and our half-life estimate offers insight into brain phospholipid AA depletion over time. One caveat to the use of these calculated half-lives, however, is that the brain appears to be capable of conserving a minimal concentration of both AA and DHA. DeMar et al. measured the rate of loss of i.c.v.-infused radiolabeled DHA from rat brain phospholipids, following 15 weeks of n-3 PUFA adequate or deprived feeding (24) .
The rates of loss were used to calculate half-lives for the two dietary groups, which were reported as 33 and 90 days for the n-3 PUFA adequate and deprived group, respectively. The prolonged half-life of the n-3 PUFA deprived group was interpreted as brain conservation of DHA. Conversion of ALA to DHA in the brain is slow (<1%), and is not increased in periods of n-3 PUFA deprivation (47) . Conservation of brain DHA may be occurring, as the enzyme thought to be responsible for cleaving DHA from brain phospholipids, calcium-inependant phospholipase A 2 (iPLA 2 ), has been shown to be down-regulated during n-3 PUFA deprivation (34). We did not observe a similar conservation of AA in our study, using the same n-3 PUFA dietary model for 15 weeks, suggesting DHA but not AA is selectively conserved in situations of n-3 PUFA deprivation. The difference between AA and DHA may be explained by the specificity of enzymes known to release AA and DHA from brain phospholipids and/or other selective catabolic reactions including β-oxidation and eicosanoid/docosanoid synthesis (57) (58) (59) .
Several studies suggest AA and DHA are preferentially released from the sn-2 position of brain phospholipids by fatty-acid selective PLA 2 (for review see Green et al., (58) Future studies are needed to confirm which plasma pool(s) contribute to brain phospholipid AA uptake.
CONCLUSION
In conclusion, we infused [ 3 H] AA in the right lateral ventricle of male Long Evans rats, following 15 weeks of n-3 PUFA adequate or deprived diet, to determine the half-life of AA in rat brain phospholipids. We calculated a half-life of 44 and 46 days for the n-3 PUFA adequate and deprived groups, respectively, which is similar to the half-life predicted from the incorporation rate of plasma unesterified [ 3 H] AA into brain phospholipids (22) . This similarity suggests the unesterified AA pool is a significant contributor to brain phospholipids. The calculated half-lives may be used as a guideline in future studies attempting to manipulate brain phospholipid AA using a dietary strategy; however, our half-lives may represent the upper-limit rate of loss, as a study using an n-6 PUFA adequate and deprived diet for 15 weeks reported a much slower rate of loss (56) . Finally, we did not observe a conservation of AA as was observed for DHA in a similar n-3 PUFA adequate and deprived 15 week feeding model (24) . This result could be explained by the selectivity of enzymes (iPLA 2 , cPLA 2 ) known to release AA and DHA from brain phospholipids; a better understanding of selectivity will be useful for pharmacological 
